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Abstract
Mammalian phospholipase Cb1 (PLCb1) is activated by the ubiquitous Gaq family of G proteins on the surface of the inner
leaflet of plasma membrane where it catalyzes the hydrolysis of phosphatidylinositol 4,5 bisphosphate. In general, PLCb1i s
mainly localized on the cytosolic plasma membrane surface, although a substantial fraction is also found in the cytosol and,
under some conditions, in the nucleus. The factors that localize PLCb1in these other compartments are unknown. Here, we
identified a novel binding partner, translin-associated factor X (TRAX). TRAX is a cytosolic protein that can transit into the
nucleus. In purified form, PLCb1 binds strongly to TRAX with an affinity that is only ten-fold weaker than its affinity for its
functional partner, Gaq. In solution, TRAX has little effect on the membrane association or the catalytic activity of PLCb1.
However, TRAX directly competes with Gaq for PLCb1 binding, and excess TRAX reverses Gaq activation of PLCb1. In C6 glia
cells, endogenous PLCb1 and TRAX colocalize in the cytosol and the nucleus, but not on the plasma membrane where TRAX
is absent. In Neuro2A cells expressing enhanced yellow and cyano fluorescent proteins (i.e., eYFP- PLCb1 and eCFP-TRAX),
Fo ¨rster resonance energy transfer (FRET) is observed mostly in the cytosol and a small amount is seen in the nucleus. FRET
does not occur at the plasma membrane where TRAX is not found. Our studies show that TRAX, localized in the cytosol and
nucleus, competes with plasma-membrane bound Gaq for PLCb1 binding thus stabilizing PLCb1 in other cellular
compartments.
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Introduction
Inositide-specific mammalian phospholipase Cbeta (PLCb)
enzymes are the main effectors of the Gaq family of G proteins
and are coupled to agents such as angiotension, dopamine,
serotonin, bradykinin, etc. (for review see [1,2,3,4]). PLCb catalyzes
the hydrolysis of the signaling lipid phosphatidylinositol 4,5
bisphosphate (PI(4,5)P2) to produce the second messengers inositol
1,4,5 trisphosphate and diacylglycerol that in turn stimulate the
release of Ca
2+ from intracellular stores and activate protein kinase
C, respectively. Both the Gaq family of G proteins and the PLCb
enzymes they activate are found in all mammalian cells lines.
In cultured cells, PLCb1 resides mainly on the surface of the
plasma membrane where it associates with its membrane-bound
activator Gaq and can access its PI(4,5)P2 substrate. In addition to
this plasma membrane population, a significant population of
PLCb1 resides in the cytosol, and under some circumstances, in
the nucleus. The factors that localize PLCb1 to these alternate
compartments are unknown, especially since PLCb1 is expected to
have a high propensity to localize to the plasma membrane due to
its strong, non-specific lipid binding behavior [5]. Additionally, the
basal activity of PLCb1 is very low and it is unclear how it can be
activated in these alternate compartments since Gaq appears to
only reside at the plasma membrane (see [6,7]).
There are several possible mechanisms that may underlie the
cytosolic localization of PLCb1. The first might be a saturation of
binding sites on the plasma membrane. While we lack the
knowledge to accurately quantify binding sites and the local
cellular concentration of competing proteins, we note that the
cellular concentration of Gaq appears to be higher than PLCb1
allowing Gaq to interact with its other effectors, phosphatidylino-
sitol 3-kinase and RhoGEF (see [8]). Another possibility is that one
or more cytosolic proteins might promote the plasma member
localization of PLCb1. With this idea in mind, we searched for
alternate protein partners of PLCb1 using a yeast two hybrid
approach and identified the protein TRAX (translin-associated
factor X). TRAX forms strong complexes with its only known
partner, translin [9]. Translin is a single-stranded DNA and RNA-
binding protein with proposed functions in chromosomal translo-
cations in lymphoid cells and mRNA transport and storage in
brain and testis [10]. Both translin and TRAX are part of the
RNA-induced silencing complex (RISC) where they help guide
double stranded RNA into the silencing machinery [11].
Additionally, TRAX has been implicated to function as a
localization factor for translin. When the cellular level of translin
exceeds TRAX, it remains in the cytosol [12]. However, when the
cellular level of translin is reduced, translin can partition into the
nucleus through the nuclear localization signal (NLS) of TRAX.
Since TRAX appears to regulate the cellular localization of
translin, it is possible that TRAX may similarly modulate the
localization of other cellular proteins. In this study, we show that
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e15001TRAX and PLCb1 interact strongly in solution and form
complexes in living cells. We find that TRAX competes with
Gaq for PLCb1 binding and activation. Our studies show that
TRAX stabilizes the cytosolic and nuclear localization of PLCb1.
Methods
Sample Preparation
Purified proteins were used in all in vitro experiments. His-
tagged PLCb1 from rat and Gaq from rat were expressed in Sf9
cells and purified based on previously described methods (see
[13,14]). Preparation of C-terminal truncated PLCb1 has been
described [5]. Large, unilamellar vesicles (LUVs), 100nm in
diameter, were prepared by extrusion. All lipids (1-palmitoyl-2-
oleoyl phosphatidylethanolamine (POPE), 1 -palmitoyl-2-oleoyl-
phosphatidylserine (POPS), 1-palmitoyl-2-oleoylphosphatidylcho-
line (POPC)) were purchased from Avanti Polar Lipids (Alabaster,
AL) with the exception of the tritiated PI(4,5)P2 which was
purchased from Perkin Elmer. Human TRAX cDNA purchased
from Open Biosystems was cloned into pET32a expression vectors
purchased from Novagen. His-tagged TRAX was expressed in
Rosetta cells and purified on a Ni-NTA column. The integrity of
the TRAX preparation was determined by western blot analysis
and circular dichroism spectra (see results).
Protein Labeling and Reconstitution
In vitro binding studies were carried out by labeling either the
PLCb1o rG aq constructs with the thiol reactive probe 7-
diethylamino-3- (49-maleimidylphenyl)-4-methylcoumarin (CPM,
Invitrogen, Inc) as previously described to yield fluorescent
proteins with an ,1:1 probe:protein ratio (see [15]). We note
that labeling by this method does not affect the activity of PLCb1
or its ability to be stimulated by Gaq (see [14]). To prevent protein
aggregation, Gaq was labeled in the presence of storage detergents
(0.1% lubrol) and was reconstituted into preformed extruded lipid
vesicles by simple addition.
Optical Measurements and Data Analysis
CD spectra were carried out on an Olis RSM 1000 CD
spectrophotometer (On-line Instrument Systems, Inc. Bogart,
GA). TRAX concentration was 20 mM in 20 mM Hepes, 0.16 M
NaCl, pH 7.4. Binding affinity measurements were performed on
an ISS spectrofluorometer (Urbana, IL) using a 3 mm cuvette (see
[15]). CPM-labeled proteins were excited at 380 nm and scanned
420 to 560 nm. Binding affinity was determined as a function of
the increase in CPM fluorescent intensity as non-fluorescent
protein was incrementally added. Briefly, the sample spectra were
corrected by subtracting out identical spectra in control cuvettes
that substituted buffer for non-fluorescent protein. The area under
the emission peaks of the corrected spectra were calculated using
ISS Vinci software. These area were then plotted as a function of
concentration of added protein, and the resulting curves were fit to
a bimolecular dissociation constant using Sigma Plot (Jandel, Inc.).
Membrane binding studies were carried out by measuring the
change in intensity of a 20 mM solution of CPM- PLCb1 as freshly
extruded large unilamellar vesicles were incrementally added. The
data were corrected for background by carrying out an identical
titration where buffer was substituted for CPM- PLCb1, The
corrected data were them fit to a hyperbolic curve using Sigmaplot
(Jandel, Inc.).
Activity Measurements
Measurements were made using full length and truncated His-
tagged PLCb1, Gaq, and TRAX and small, unilamellar vesicles
consisting of PI(4,5)P2, POPE, POPS (1:1:1) doped with
3H-
PI(4,5)P2 prepared by sonication (see [13]). Briefly, 2mM of lipid
were incubated at 37uC with PLCb1 in the linear range of the
activity as determined for each by running a time course
experiment (usually between 2 and 5 minutes). The reaction was
initiated by the addition of Ca
2+. Activities are reported as the
percent of radioactive PI(4,5)P2 hydrolysis that occurred.
Cell Culture
Neuro2A cells from American Type Culture Collection (www.
ATCC.org) were cultured in 50/50 DMEM/F12 media supple-
mented 10% FBS. C6 glioma cells were cultured in DMEM
containing 10% FBS, 100mM sodium pyruvate and 1% PenStrep
at 37u C with 5% CO2.
DNA was transfected into cells by electroporation using a
protocol adapted from Maniatis. Cells were grown to near 100%
confluence and washed with sterile PBS. The cells were then
trypsinized, centrifuged 5 minutes at 15006g and resuspended in
10mL of fresh growth medium. 800 ml of cells were pipeted into a
0.4cm BioRad cuvette and placed in an electroporator (BioRad
Gene Pulser Xcell). Cells were then plated and covered with fresh
medium.
Immunofluorescence
Cells were fixed and stained with primary antibodies to TRAX
and PLCb1 (Santa Cruz Biochemicals, Inc.). In certain cases as
noted in the text, eYFP-tagged PLCb1was transfected via
electroporation prior to fixing. Cells were initially washed with
PBS + 1mM Ca
2+ and 2 mM Mg
2+. Cells were then fixed with
3.7% formaldehyde in PBS and permeabilized with a solution of
0.2% NP40 in PBS. After, the cells were blocked in 4% goat serum
in 1X TBS, washed and a primary antibody added. Cells were
incubated for 1 hour, washed and treated with a secondary
antibody. After another wash, the cells were viewed on either a
Zeiss Axiovert 200M with an AxioCam MRm camera, or an
Olympus Fluoview FV1000 laser confocal microscope. Data were
analyzed using either Olympus (Fluoview) software or Image J
(NIH).
FRET analysis
A fully functional eYFP-tagged PLCb1 was cotransfected with
TRAX fused with eCFP. Cells were allowed to incubate for 48
hours. Afterwards the live cells were viewed through the CFP, YFP
and FRET channels and FRET measurements on regions of
interest were made using sensitized emission on an Olympus
Fluoview FV1000 laser confocal microscope (for details, see [16]).
Analysis was done using Fluoview software (Olympus, Inc.).
Results
Identification of TRAX as a PLCb1 binding partner
A yeast two-hybrid (Y2H) screen of a rat brain library with the
C2 domain-containing COOH-terminus of rat PLCb1 (a.a. 643-
1216) was performed to identify novel interacting partners
important to the functional regulation of PLCb1 and uncovered
the TRPM7 ion channel as a binding partner [17,18]. Among the
69 rat Y2H clones from the screen that were sequenced based on
selected growth and b-galactosidase activity, three overlapping
clones were identified as translin-associated factor X (TRAX).
Since TRAX has a cytosolic and nuclear localization, we carried
out further tests to determine whether it is a PLCb1 binding
partner.
Initially, we directly measured the association between purified
TRAX and purified PLCb1 in solution. While the integrity of
TRAX Binds to Phospholipase Cb1
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ability to be activated by Gaq, TRAX does not have a catalytic
function. Thus, we determined whether TRAX was folded
properly by circular dichroism (CD) spectroscopy. In Fig. 1 we
show the CD spectrum of a solution of 20 mM TRAX in buffer.
We find that the TRAX CD spectrum displays a high degree of
secondary structure that corresponds to ,80% helical content
(http://www.embl.de/ ˜andrade/k2d). This high helical content
is expected from its sequence where it is predicted to have over
50% helical structure with the remainder being loops (www.
predictprotein.org).
We measured the association between TRAX and PLCb1 using
fluorescence methods. In these experiments His6- PLCb1 was
expressed in Sf9 cells and purified, and then labeled with the
fluorescent probe CPM (diethylamino-3- (49-maleimidylphenyl)-4-
methylcoumarin). We then monitored changes in the fluorescence
spectrum of CPM- PLCb1 with the addition of purified TRAX
(see methods and [15] for details). We find that the fluorescence
intensity increased systematically with the addition of TRAX
without a significant shift in the emission spectrum. Fitting this
increase (an 80% increase relative to control samples that did not
contain TRAX) to a bimolecular dissociation curve gives an
apparent dissociation constant of Kd=8+/21n M ( Fig. 2a).
Interestingly, this apparent Kd is only ,10 fold weaker than the
one measured for the interaction between PLCb1 and activated
Gaq [14]. We repeated the titration using an initial concentration
of PLCb1 that is above the Kd, 10 nM, to verify that the
association was shifted to the stoichiometric regime, and a
midpoint of 10 nM was obtained (data not shown).
The COOH-terminal region of PLCb1 was used as bait to
identify TRAX in the yeast 2-hybrid screen suggesting that this
region binds TRAX. Therefore, we repeated the fluorescence
binding study using a COOH-terminal deletion mutant of PLCb1
(PLCb1–DC). We find that the loss of the C-terminus results in a
drastic reduction in its affinity for TRAX (Fig. 2b). This result
confirms that the primary interaction site between TRAX and
PLCb1 is within C-terminal region. Thus, all further experiments
used the full length enzyme.
TRAX competes with Gaq-GTP for binding to PLCb1
PLCb1 strongly associates with Gaq-GTP on membrane
surfaces (Kd=0.67 nM) through sites in its C2 and COOH-
terminal regions [19,20]. Since both TRAX and Gaq bind to the
COOH-terminal region, we asked whether TRAX would compete
with binding of Gaq to full length PLCb1. For these studies,
purified Gaq activated with non-hydrolyzable GTPcS was labeled
with CPM and reconstituted onto large unilamellar vesicles
(LUVs) composed of POPC:POPS:POPE (1:1:1). We measured
the dissociation constant between PLCb1 and Gaq-GTPcS in the
absence and presence of excess TRAX (300nM). The presence of
TRAX resulted in a 3-fold reduction in PLCb1- Gaq-GTPcS
binding affinity, showing that TRAX competes with Gaq for
binding to PLCb1( Fig 3a).
We repeated the above study substituting unactivated
Gaq(GDP) for activated Gaq (GTPcS). It is worth noting that in
the deactivated state, the affinity between Gaq and PLCb1i s
reduced by a factor of ,50 [14] giving rise to large experimental
error. As expected, we find that TRAX does not appear to
compete with deactivated Gaq for binding to PLCb1. This result
may suggest that deactivation of Gaq (GDP) alters its binding
interaction with PLCb1, consistent with previous work [6], to a
site that is less competitive for TRAX association (Fig. 3b).
PLCb1 binds strongly to lipid membranes where it associates
with Gaq and accesses its substrate. Membrane binding of PLCb1
has been found to be primarily mediated through the N-terminal
PH domain of PLCb1 and to a lesser extent, its C-terminal region
[5]. Since TRAX might affect the association between PLCb1 and
Gaq by altering its membrane binding affinity, we determined
Figure 1. The structure of TRAX is mainly helical. Circular dichroism spectrum of 20 mM TRAX in 20 mM Hepes, 160 mM NaCl, pH 7.4.
doi:10.1371/journal.pone.0015001.g001
TRAX Binds to Phospholipase Cb1
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membranes. We find it does not (Fig. 3c). A lack of effect of
TRAX on the membrane binding of PLCb1 correlates well with
the finding that TRAX associates with the C-terminal region and
not the N-terminal membrane binding region.
TRAX interferes with the activation of PLCb1b yG aq
subunits
We next determined whether TRAX has the ability to modulate
the enzymatic activity of PLCb1 or its activation by Gaq. These
studies were carried out by monitoring the amount of PI(4,5)P2
hydrolysis catalyzed by 2 nM PLCb1 in the presence and absence
of TRAX. We find that a 300 molar excess of TRAX does not
greatly affect the initial velocity of the reaction catalyzed by
PLCb1, but reduces the velocity at later times, suggesting that
TRAX causes a small reduction in the maximum rate (Fig. 4a).
We then tested whether TRAX could block PLCb1 activation by
Gaq. Again, a large excess of TRAX was used to allow it to
compete with Gaq, which binds PLCb1 much more strongly. We
find that TRAX prevents the activation of PLCb1b yG aq
(Fig.4b), which is consistent with the ability of TRAX to disrupt
the association between PLCb1 and Gaq (GTPcS) (Fig.3a).
TRAX and PLCb1 are associated in cultured cells
We verified that TRAX and PLCb1 associate in cells using
fluorescence microscopy. First, we used immunofluorescence to
determine whether endogenous TRAX and endogenous PLCb1
are colocalized in C6 glia cells. The images in Fig. 5 show almost
complete colocalization of the proteins throughout the cell
suggesting association between the two proteins.
Since colocalization will only indicate whether the proteins
reside in the same region of the cell, we measured the physical
association of TRAX and PLCb1b yF o ¨rster resonance energy
transfer (FRET) using attached ‘‘donor’’ and ‘‘acceptor’’ fluores-
cent probes. For these studies, we linked enhanced yellow
fluorescence proteins (eYFP) to PLCb1 and enhanced cyano
fluorescence protein (eCFP) to TRAX. The observation of FRET
from eCYP donors to eYFP acceptors indicates that the probes are
at least within 30 A ˚ of each other [21], implying that the two
labeled proteins are physically associated.
We transfected Neuro2A cells with eYFP- PLCb1 and eCFP-
TRAX and measured the amount of FRET by sensitized emission
(see methods) using a confocal microscope. FRET values were
compared to a positive control consisting of eYFP-X12-eCFP and a
negative control consisting of free eYFP and eCFP (see [6]). An
example of a FRET study is shown in Fig. 6. We find that a large
degree of FRET occurs between the proteins in the cytosol while
only a small amount is seen in the nucleus and none on the plasma
membrane compartments since TRAX does not localize to this
compartment and cannot provide donor energy for FRET (Fig. 6).
Averaging the amount of FRET over the entire cell gives a value of
40.1+0.6% (n=5). The lack of FRET in the nucleus contrasts with
the coimmunofluorescence results in C6 glia cells and can be
explained by a lack of PLCb1 in the nuclear compartment. Thus,
these studies show that TRAX and PLCb1 associate in the cytosol
of cells.
Discussion
In this study, we have identified TRAX as a novel cellular
binding partner of PLCb1. The potential interaction between
PLCb1 and TRAX was found in a yeast 2-hybrid experiment
using the 574 residue C2-domain containing COOH-terminal
region of PLCb1 as bait, and subsequent binding studies between
the purified proteins verified this interaction.
The binding of TRAX to the COOH-terminal region of PLCb1
suggests that this interaction is specific to the PLCb family rather
than the other known mammalian families of PLCs (i.e. d,c,e and
f) since this region of PLCb is not found in other PLCs. This
Figure 2. TRAX binds strongly to PLCb1. A – Binding of TRAX to 2 nM CPM- PLCb1 as monitored by the increase in CPM intensity where the
normalized fluorescence intensity is shown as a function of TRAX concentration. In these studies, an 80% increase in intensity was observed as
compared to control samples that substituted buffer for TRAX. Also shown is the fitted curve to a bimolecular dissociation constant where Kd=861
nM (n=6 and S.D. is shown). B – Identical study as 2A except that the COOH-terminal deletion mutant of PLCb1 (PLCb1-DC) was used instead of the
full length enzyme (n=3 and S.D. is shown). While a binding curve is shown to guide the eye, the affinity between the proteins was too weak to be
accurately fit to a bimolecular dissociation constant. We note that the total change in CPM intensity was also ,80% at the end of the titration.
doi:10.1371/journal.pone.0015001.g002
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PLCb1 (a nuclear export signal on PLCb has never been
identified), as well as mitogen-activation protein kinase and
protein kinase C phosphorylation sites (we note that unpublished
studies by our group suggest that PKC phosphorylation does not
affect the interaction between TRAX and PLCb1: Aisiku, Dowal
& Scarlata, unpublished). Importantly, the COOH-terminal region
of PLCb1 is necessary for Gaq activation, and has GTPase-
promoting activity [19,22]. Therefore, it is not surprising that
TRAX competes with Gaq for binding to PLCb1. The crystal
structure of the isolated COOH-terminal region of PLCb1 has
been solved and is found to be an intertwined helical dimer [23],
although it is not clear whether PLCb1 itself is dimeric. While it is
impossible to speculate the mode of interaction between TRAX
and PLCb1, it is notable that translin, TRAX’s known binding
partner, is comprised of a network of helixes [24].
We assessed the association between endogenous TRAX and
PLCb1 in C6 glial cells, which express these proteins at high levels.
We speculate that the high level of expression of PLCb1 in these
cells is responsible for the large cytosolic population since all of the
plasma membrane localized Gaq binding sites may be saturated.
We find that the two proteins co-localize throughout the cell. We
then visualized the associated proteins using FRET by co-
expressing fluorescent tagged proteins in a cell line where their
endogenous expression is more limited (i.e. Neuro2A cells). We
find that the proteins complexes largely reside in the cytosol, since
little PLCb1 localizes to the nucleus and since TRAX is not found
on the plasma membrane in these cells. Interestingly, the FRET
values that have been reported for PLCb1 and Gaq [6] are close to
the FRET values between PLCb1 and TRAX observed here.
PLCb1 is known to have a high plasma membrane population due
to its strong interaction with Gaq both in the basal and stimulated
states [6]. The ability of TRAX to hold PLCb1 in the cytosol
despite the higher affinity of the enzyme for Gaq and the
concentrating effect of the membrane in promoting protein
association correlates well with the strong association between
TRAX and PLCb1. It is interesting to note that recent
biochemical studies suggest that Gaq and PLCb1 bind to a
protein scaffold on the plasma membrane which stabilizes their
interactions [25].
Figure 3. TRAX competes with Gaq for PLCb1 binding but not membranes. A – Binding of PLCb1 to 2 nM activated CPM- Gaq(GTPcS) in the
absence (N) and presence (#) of 200 nM TRAX right panel showing the loss in Gaq affinity when TRAX is present, where n=6 and S.D. is shown. We
note that an ,20% increase in CPM intensity was seen both without and with TRAX. B- Binding of PLCb1 to 2 nM deactivated CPM- Gaq(GDP) in the
absence (N) and presence (#) of 200 nM TRAX, where n=3 and S.D. is shown. C- Binding of PLCb1 to PC:PS:PE (1:1:1) large, unilamellar vesicles in the
absence (N)( K p=132 mM) and presence (#)( K p=120 mM) of 200 nM TRAX as measured by the increase in CPM intensity as LUVs are titrated into the
solution, where n=3 and S.D. is shown.
doi:10.1371/journal.pone.0015001.g003
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PLoS ONE | www.plosone.org 5 November 2010 | Volume 5 | Issue 11 | e15001Figure 4. TRAX affects the activation of PLCb1b yG aq.A– The effect of 300 nM TRAX on the rate of PI(4,5)P2 hydrolysis catalyzed by 25nM
PLCb1 (n=3 and S.D. is shown). As can be seen, TRAX does not affect the initial velocity of the curve. B- Prevention of activation of 5 nM PLCb1b y
5nM Gaq by 300 nM TRAX, where n=8 and S.D. is shown.
doi:10.1371/journal.pone.0015001.g004
Figure 5. TRAX and PLCb1 co-localize in C6 glial cells. Example of a co-immunofluorescence study of endogenous PLCb1( left panel)a s
visualized by Alexa488-labeled antibody, TRAX (middle panel) visualized by Alexa647-labeled antibody and the resulting merged image (right panel)i n
C6 glial cells. The scale bar is 5 mm.
doi:10.1371/journal.pone.0015001.g005
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a significant amount is also seen in the cytosol. Additionally, we
can only speculate about the function of PLCb1 in the cytosol.
While its activity is expected to be too low to impact the level of
PI(4,5)P2 levels in internal membranes, it might be sufficient to
keep internal PI(4,5)P2 at basal levels.
In C6 glia cells, TRAX and PLCb1 appear to be co-localized in
the nucleus as well as the cytosol. Since both proteins have a
nuclear localization sequence, it is just as likely that either partner
could be responsible for nuclear transit. Nuclear transit might
occur through exposure of either nuclear localization signal upon
protein association or upon saturation of PLCb1’s plasma
membrane and cytosolic sites. Although PLCb1 is not considered
a nuclear protein, it has been found in the nucleus under some
conditions (see [26,27]). We observe large amount of the enzyme
in undifferentiated PC12 cells (Dowal & Scarlata, unpublished).
Cocco and colleagues find PLCb1 travels to the nucleus in Swiss
3T3 cells upon stimulation with insulin-like growth factor [28].
The role of PLCb1 in the nucleus is unknown, but is assumed to be
involved in the nuclear phosphadylinositol signaling pathway [29].
It is notable that PLCb1 does not appear to be associated with the
nuclear membrane.
The identification of TRAX as a potential binding partner of
PLCb1 is surprising since TRAX is not known to be associated
with inositol phosphate signaling. One study did report a link
between TRAX and activation of a G protein coupled receptor
linked to cAMP [30] giving rise to the possibility that TRAX may
modulate additional aspects of G protein signaling. To date,
TRAX has only been known to bind to translin and modulate its
cellular localization [12]. It has recently been found that TRAX
and translin are part of the RNA-induced silencing complex, and
their presence helps to guide RNA insertion into the complex to
induce gene silencing [11]. PLCb1 has been shown to reside in
nuclear speckles [29,31] which are storage deposits for splicing
factors and other transcription machinery (for review see [32]).
The localization of PLCb1 in speckles suggests a possible role in
RNA splicing and/or in mRNA processing.
While the strong binding constant and large FRET value
measured for cytosolic PLCb1 and TRAX suggest a specific
cellular role, the functional consequence of these proteins’
association is not yet clear. Unfortunately, we do not yet have
the ability to accurately measure the concentrations of these
proteins in the cell, but realize that these numbers will change will
cell type, localization, cycle and differentiation. Therefore, we
cannot determine the importance of TRAX in regulating the
localization of PLCb1 at this time. One possibility is that TRAX
buffers PLCb1 in the cytosol until Gaq becomes activated to high
enough levels to displace TRAX from PLCb1. TRAX may also
regulate the entry of PLCb1 into the nucleus so that it may
participate in RNA processing. Alternately, PLCb1 may regulate
entry of TRAX into the nucleus or its association to translin.
These functional studies are presently underway.
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